Clinical trial
A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma
NCT03857763 is registered in ClinicalTrials.gov with Hebei Medical University Fourth Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma
- Lead sponsor
- Hebei Medical University Fourth Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- March 1, 2019
- Completion date
- March 1, 2023
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.